Nova EYE Medical Ltd (eye) Logo

Nova EYE Medical Ltd (EYE)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

EYE ASX Chart

Snapshot

Nova Eye Medical Limited (EYE) is into design, development, manufacture, marketing and sales of surgical devices for the treatment of glaucoma, a leading cause of blindness. In addition, the Company is engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser, 2RT, for the treatment of retinal disease via the AlphaRET segment.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) +22.85%
vs ASX 200 (1yr) +21.03%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,296 of 2,357
Sector Rank 116 of 230

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies UBI / SHG / CVB
EPS -$0.043
DPS $0.00
Book Value Per Share $0.062

Broker Consensus

EYE is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Kent Town SA 5067
Website www.nova-eye.com
Registry Link Market Services
Auditor PricewaterhouseCoopers
Date Listed 12 Sep 1994

Upcoming Calendar (Forecasted)

Date Event
21/02/2025 Report (Interim)
25/08/2025 Report (Prelim)
25/08/2025 Report (Annual)

Former Company Names

  • Ellex Medical Lasers Limited (ELX), 02/07/2020
  • Ellex Medical Lasers Limited (ELX), 31/07/2001
  • Gemstone Corporation of Australia Ltd (GEC), 04/01/1987

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
21/07/2020 $0.135 100% $0.1929 Interim 29/07/2020

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.00
Gross DPS(TTM) $0.00
Dividend yield
Gross yield
Payout Ratio --
DRP No
DRP Features -

Directors & Management

Directors

Management

Director Transactions

EYE directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
28/11/24 Thomas (Tom) Spurling Issued 300,000 $0.155 $46,500 Issue of securities
27/11/24 Thomas (Tom) Spurling Expiry 700,000 $0.145 $101,500 Options expired
15/03/24 Victor Previn Issued 1,233,948 $0.21 $259,129 Rights issue
15/03/24 Thomas (Tom) Spurling Issued 62,700 $0.21 $13,167 Rights issue
15/03/24 Thomas (Tom) Spurling Issued 31,217 $0.21 $6,555 Rights issue
15/03/24 Rahmon Coupe Issued 149,022 $0.21 $31,294 Rights issue
15/11/23 Thomas (Tom) Spurling Buy +200,000 $0.125 $25,009 On-market trade
05/05/23 Daniel Webb Buy +555,556 $0.18 $100,000 Placement
05/05/23 Rahmon Coupe Buy +277,778 $0.18 $50,000 Placement
05/05/23 Victor Previn Buy +555,556 $0.18 $100,000 Placement
05/05/23 Thomas (Tom) Spurling Buy +111,110 $0.18 $19,999 Placement
24/11/21 Alexander Sundich Transfer 1,000,000 $0.37 $370,000 Off-market transfer
24/11/21 Alexander Sundich Transfer 1,000,000 $0.37 $370,000 Off-market transfer
18/09/20 Thomas (Tom) Spurling Buy +20,000 $0.34 $6,800 On-market trade
26/09/18 Mike Southard Buy +20,000 $0.746 $14,910 On-market trade
07/05/18 Rahmon Coupe Buy +13,749 $0.74 $10,174 On-market trade
04/10/16 Rahmon Coupe Sell +54,600 $1.19 ($65,246) On-market trade
03/06/16 Giuseppe Canala Transfer 15,000 $1.00 $15,000 Off-market transfer
03/06/16 Giuseppe Canala Transfer 15,000 $1.00 $15,000 Off-market transfer
03/06/16 Giuseppe Canala Sell +1,000,000 $0.99 ($990,000) On-market trade

Director Interests

The current holdings of EYE directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Thomas (Tom) Spurling 27/11/2024 564,303 280,953 0 N/A
Daniel Webb 30/06/2024 N/A 555,556 N/A N/A
Mike Southard 30/06/2024 N/A 20,000 N/A N/A
Rahmon Coupe 30/06/2024 N/A 1,341,200 N/A N/A
Victor Previn 30/06/2024 N/A 11,105,535 N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 26, 2024.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
National Nominees Limited 40,113,310 17.51%
J P Morgan Nominees Australia Pty Limited 10,274,698 4.49%
Sedico Pty Ltd <Victor Previn Family A/C> 8,175,353 3.57%
Ruminator Pty Ltd 5,694,759 2.49%
Canala Super Fund Pty Ltd <Giuseppe Canala Sf A/C> 4,515,857 1.97%
Citicorp Nominees Pty Limited 3,519,291 1.54%
Highlands Investments Holdings Pty Ltd 2,600,113 1.14%
BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 2,184,484 0.95%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 2,157,360 0.94%
Sean Barrett Pty Ltd <Super Fund A/C> 2,030,000 0.89%
Super Wide Pty Ltd <Super Wide Super Fund A/C> 1,900,717 0.83%
Dinwoodie Investments Pty Ltd 1,856,714 0.81%
Mrs Glenis Nita O'Donnell 1,800,465 0.79%
Toucan Trading Pty Ltd 1,781,716 0.78%
Mr John Kwok Mun Yuen 1,776,312 0.78%
BNP Paribas Noms Pty Ltd 1,746,547 0.76%
Innovative Glaucoma Solutions Llc 1,736,653 0.76%
Mr Anthony William Scott 1,622,195 0.71%
HSBC Custody Nominees (Australia) Limited 1,607,554 0.70%
Pine Street Pty Ltd <Pine Street A/C> 1,406,250 0.61%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 116 866 500 1,154 285 2,921

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Natioanl Nominees (Australian Ethical Investment) 26/08/2024 40,113,310 17.51

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
15-03-24 Natioanl Nominees (Australian Ethical Investment) 12,528,303 19.20 17.53

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
15-03-24 Jencay Capital Pty Limited 13,287,956 6.98 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2024 $0.22 28 June
2023 $0.265 30 June
2022 $0.185 30 June
2021 $0.32 30 June
2020 $0.68 30 June
2019 $0.53 28 June
2018 $0.61 29 June
2017 $1.07 30 June
2016 $0.955 30 June
2015 $0.33 30 June
2014 $0.375 30 June
EYE Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.